Evidence map›Paper›PMID 33772862›Full record

Trial reportDiabetic medicine : a journal of the British Diabetic Association2021

'I was ready for it at the beginning': Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis.

Molly L Tanenbaum, Dessi P Zaharieva, Ananta Addala, Jessica Ngo, Priya Prahalad, Brianna Leverenz, Christin New, David M Maahs, Korey K Hood

Abstract readPragmatic Clinical Trial
In one paragraph

Trial report in Diabetic medicine : a journal of the British Diabetic Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers.Clinical diabetes : a publication of the American Diabetes Association · 2024
    Article
  17. Role and Perspective of Certified Diabetes Care and Education Specialists in the Development of the 4T Program.Diabetes spectrum : a publication of the American Diabetes Association · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Molly L TanenbaumDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0003-4222-4224
Dessi P ZaharievaDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.
Ananta AddalaDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0002-0508-4309
Jessica NgoDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.
Priya PrahaladDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.
Brianna LeverenzDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.
Christin NewDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.
David M MaahsDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0002-4602-7909
Korey K HoodDivision of Endocrinology, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T StudyR18DK122422 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2020 to 2024
$3.2M
Training Research Leaders in Type 1 DiabetesK12DK122550 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2019 to 2023
$2.1M
ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes DevicesK23DK119470 · NIDDK · STANFORD UNIVERSITY · PI TANENBAUM, MOLLY LEAH · 2019 to 2023
$988k
NIDDK NIH HHS K12 DK122550NIDDK NIH HHS K23 DK119470NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R18 DK122422
6 · The paper itself

Abstract

aimThis study aimed to capture the experience of parents of youth with recent onset Type 1 diabetes who initiated use of continuous glucose monitoring (CGM) technology soon after diagnosis, which is a new practice.

methodsFocus groups and individual interviews were conducted with parents of youth with Type 1 diabetes who had early initiation of CGM as part of a new clinical protocol. Interviewers used a semi-structured interview guide to elicit feedback and experiences with starting CGM within 30 days of diagnosis, and the benefits and barriers they experienced when adjusting to this technology. Groups and interviews were audio recorded, transcribed and analysed using content analysis.

resultsParticipants were 16 parents (age 44.13 ± 8.43 years; 75% female; 56.25% non-Hispanic White) of youth (age 12.38 ± 4.15 years; 50% female; 50% non-Hispanic White; diabetes duration 10.35 ± 3.89 months) who initiated CGM 11.31 ± 7.33 days after diabetes diagnosis. Overall, parents reported high levels of satisfaction with starting CGM within a month of diagnosis and described a high level of reliance on the technology to help manage their child's diabetes. All participants recommended early CGM initiation for future families and were committed to continue using the technology for the foreseeable future, provided that insurance covered it.

conclusionParents experienced CGM initiation shortly after their child's Type 1 diabetes diagnosis as a highly beneficial and essential part of adjusting to living with diabetes.

Indexed as

Early DiagnosisParentsAdolescentAdultBlood GlucoseBlood Glucose Self-MonitoringChildChild, PreschoolDiabetes Mellitus, Type 1FemaleFollow-Up StudiesHumansHypoglycemic AgentsInsulin Infusion SystemsMaleMiddle AgedBlood GlucoseHypoglycemic Agentschildren and adolescentsdeviceshealth care deliverypsychological aspects

Identifiers

PMID33772862
PMCPMC8480902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.